VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CRVLCorVel Corporation
$58.52$3.0B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCRVLPrice Target
CRVL logo

CorVel Corporation (CRVL) Price Target Analysis

Analyst Rating:
Based on 0 analysts

No Target Data

CRVL trades at Wall Street's consensus target of —.

Current Price$58.52
Average Target—
Low—
Median—
High—

Analyst Target Range

Forward P/E33.6x
(Growth Premium)
PEG Ratio—
Implied Growth-19.1%
(Declining)
Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$58.52
Consensus—
High—
Low—

Consensus Scenario Assumptions

The base valuation assumes CRVL achieves its forward estimates and maintains a stable P/E multiple of 33.6x. This scenario reflects the blended consensus of multiple Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings

No analyst coverage available for CRVL

Coverage appears once Wall Street estimates are published.

CRVL Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, CorVel Corporation (CRVL) has a Wall Street consensus price target of N/A, based on estimates from 0 covering analysts. The company has a market capitalization of $2.97B.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is N/A, with 0 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.

From a valuation perspective, CRVL trades at a trailing P/E of 27.3x and forward P/E of 33.6x. Analysts expect EPS to grow -19.1% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $58.94, with bear and bull scenarios of $37.13 and $77.66 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Financial Services stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+6.2%
Industry Consensus
Avg Forward P/E
15.9x
(Fair)
Peers with Coverage
8 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
MGRC logo
MGRCMcGrath RentCorp
$2.9B$118.19$140.00
+18.5%
Buy18.6x5
GBLI logo
GBLIGlobal Indemnity Group, LLC
$364M$25.34———9.4x—
MCRB logo
MCRBSeres Therapeutics, Inc.
$64M$6.61$1.25
-81.1%
Buy—18
AMSF logo
AMSFAMERISAFE, Inc.
$589M$31.32$44.50
+42.1%
Buy14.9x6
EHTH logo
EHTHeHealth, Inc.
$51M$1.65—————
PINC logo
PINCPremier, Inc.
$2.3B$28.26$33.15
+17.3%
Hold20.8x31
MCK logo
MCKMcKesson Corporation
$90.2B$750.63$994.86
+32.5%
Buy17.0x31
TDOC logo
TDOCTeladoc Health, Inc.
$1.5B$8.07$7.40
-8.3%
Hold—42
UNH logo
UNHUnitedHealth Group Incorporated
$363.9B$400.96$425.81
+6.2%
Buy21.8x52
CI logo
CICigna Corporation
$73.6B$279.27$340.91
+22.1%
Buy9.2x39

CRVL — Frequently Asked Questions

Quick answers to the most common questions about buying CRVL stock.

What is the CRVL stock price target for 2026?

The consensus price target for CRVL is $N/A, close to the current price of $58.525 (N/A% implied move). Based on 0 analyst estimates, the stock appears fairly valued near current levels.

Is CRVL a buy, sell, or hold?

CRVL has a consensus rating of "N/A" based on 0 Wall Street analysts. The rating breakdown is mixed, with 0 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is CRVL stock overvalued or undervalued?

CRVL trades at a forward P/E of 33.6351x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.

How high can CRVL stock go?

The most bullish Wall Street analyst has a price target of $N/A for CRVL, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $78 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover CRVL stock?

CRVL is lightly followed, with 0 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the CRVL stock forecast?

The 12-month CRVL stock forecast based on 0 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "N/A". Our proprietary valuation model produces a base case fair value of $59, with bear/bull scenarios of $37/$78.

What is CRVL's fair value based on fundamentals?

Our quantitative valuation model calculates CRVL's fair value at $59 (base case), with a bear case of $37 and bull case of $78. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.

What is CRVL's forward P/E ratio?

CRVL trades at a forward P/E ratio of 33.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.3x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy CRVL stock?

CRVL appears fairly valued according to analysts, with a "N/A" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do CRVL price targets vary so much?

CRVL analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $37-$78 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare